Multiple pharmacokinetic parameter prediction for a series of cephalosporins.
暂无分享,去创建一个
Snezana Agatonovic-Kustrin | J. V. Turner | D. Cutler | S. Agatonovic-Kustrin | Joseph V Turner | Desmond J Maddalena | David J Cutler | D. Maddalena
[1] H. Black,et al. A comprehensive review of the clinical pharmacology and pharmacokinetics of cefaclor. , 1988, Clinical Therapeutics.
[2] K Krishnan,et al. Quantitative structure-pharmacokinetic relationship modelling. , 2001, The Science of the total environment.
[3] R. Quintiliani,et al. Clinical Pharmacokinetics of Ceftriaxone , 1989, Clinical pharmacokinetics.
[4] P. Hinderling,et al. Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man , 1984, Journal of Pharmacokinetics and Biopharmaceutics.
[5] L. Wiseman,et al. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential. , 1993, Drugs.
[6] Anthony Long,et al. Computer systems for the prediction of xenobiotic metabolism. , 2002, Advanced drug delivery reviews.
[7] Jorge Gálvez,et al. Charge Indexes. New Topological Descriptors , 1994, J. Chem. Inf. Comput. Sci..
[8] M Danhof,et al. Multivariate quantitative structure-pharmacokinetic relationships (QSPKR) analysis of adenosine A1 receptor agonists in rat. , 1999, Journal of pharmaceutical sciences.
[9] M. Hosseini,et al. Using Artificial Neural Networks To Classify the Activity of Capsaicin and Its Analogues , 1997, J. Chem. Inf. Comput. Sci..
[10] M. Dudley,et al. Review of cefonicid, a long-acting cephalosporin. , 1984, Clinical Pharmacist.
[11] S Agatonovic-Kustrin,et al. Theoretically-derived molecular descriptors important in human intestinal absorption. , 2001, Journal of pharmaceutical and biomedical analysis.
[12] W. Shelver,et al. Quantitative structure-pharmacokinetic relationships (QSPR) of beta blockers derived using neural networks. , 1995, Journal of pharmaceutical sciences.
[13] T. Bergan. Comparative pharmacokinetics of cefazolin, cephalothin, cephacetril, and cephapirine after intravenous administration. , 1977, Chemotherapy.
[14] L. Benet,et al. Pharmacokinetics of cefamandole using a HPLC assay , 1978, Journal of Pharmacokinetics and Biopharmaceutics.
[15] P. Veng‐Pedersen,et al. Quantitative structure-pharmacokinetic relationships for systemic drug distribution kinetics not confined to a congeneric series. , 1994, Journal of pharmaceutical sciences.
[16] P. Godley,et al. Cefpodoxime Proxetil: A New, Broad-Spectrum, Oral Cephalosporin , 1993, The Annals of pharmacotherapy.
[17] G. Grass,et al. Physiologically-based pharmacokinetic simulation modelling. , 2002, Advanced drug delivery reviews.
[18] M. Reinhard,et al. Handbook for estimating physicochemical properties of organic compounds , 1999 .
[19] Patrick Poulin,et al. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition. , 2002, Journal of pharmaceutical sciences.
[20] J. Hamilton-miller,et al. Cefaclor into the millennium. , 1999, Journal of chemotherapy.
[21] D. Spyker,et al. Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects , 1981, Antimicrobial Agents and Chemotherapy.
[22] J. Flaherty,et al. Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure , 1989, Clinical pharmacology and therapeutics.
[23] Lotfi A. Zadeh,et al. The Roles of Fuzzy Logic and Soft Computing in the Conception, Design and Deployment of Intelligent Systems , 1997, Software Agents and Soft Computing.
[24] L. Thomachot,et al. Clinical Pharmacokinetics of Cefotetan , 1994, Clinical pharmacokinetics.
[25] F. Aoki,et al. Pharmacokinetic Disposition of Loracarbef in Healthy Young Men and Women at Steady State , 1994, Journal of clinical pharmacology.
[26] R. N. Brogden,et al. Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. , 1993, Drugs.
[27] T. Schwinghammer,et al. Pharmacokinetics of Cephradine Administered Intravenously and Orally to Young and Elderly Subjects , 1990, Journal of clinical pharmacology.
[28] P. Welling,et al. A pharmacokinetic comparison of cephalexin and cefadroxil using HPLC assay procedures. , 1985, Biopharmaceutics & drug disposition.
[29] J. Gálvez,et al. Pharmacological distribution diagrams: a tool for de novo drug design. , 1996, Journal of molecular graphics.
[30] J. Flaherty,et al. Third-generation cephalosporins: a critical evaluation. , 1984, Clinical pharmacy.
[31] Jesús Vicente de Julián-Ortiz,et al. Topological Approach to Drug Design , 1995, J. Chem. Inf. Comput. Sci..
[32] Malcolm Rowland,et al. Clinical pharmacokinetics : concepts and applications , 1989 .
[33] W. Adams,et al. Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination , 1989, Antimicrobial Agents and Chemotherapy.
[34] R. N. Brogden,et al. Cefixime , 1989, Drugs.
[35] S. Agatonovic-Kustrin,et al. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. , 2000, Journal of pharmaceutical and biomedical analysis.
[36] A Bucinski,et al. Pharmacological classification of drugs based on neural network processing of molecular modeling data. , 2000, Combinatorial chemistry & high throughput screening.
[37] D. Spyker,et al. Pharmacokinetics of Cefaclor and Cephalexin: Dosage Nomograms for Impaired Renal Function , 1978, Antimicrobial Agents and Chemotherapy.
[38] H. Lode,et al. Comparative pharmacokinetics of cefoperazone and cefotaxime. , 1980, Clinical therapeutics.